SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more
Pankajakasthuri declares final clinical trials of ZingiVir-H as adjunct therapy for COVID-19 patients Read more
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against COVID-19 Read more